On this episode of the CEO Podcast, Clint sat down with Will Lewis, the CEO of Innsmed, a company dedicated to developing innovative drugs for patients facing serious and rare diseases. Will shares his journey to becoming CEO, the transformative growth of Innsmed, and the intricate process of drug development, including the lengthy timelines and significant financial investments involved. They discuss the importance of patient experience, the ethical considerations in drug development, and the role of artificial intelligence in streamlining processes. Will also offers insights into leadership, mentorship, and the values that drive his team to make a meaningful difference in patients' lives.  Timestamps: 00:00 - Introduction to Innsmed and CEO Journey 00:38 - Overview of Innsmed's Mission 01:39 - The Drug Development Process 04:04 - The Necessity of the 15-Year Process 06:38 - Expedited Drug Development During COVID-19 08:12 - Choosing Which Diseases to Target 10:51 - The Future of Curing Diseases 12:55 - The Role of Artificial Intelligence in Drug Development 16:21 - A Day in the Life of the CEO 18:05 - Leadership Philosophy and Values 20:18 - Reading Recommendations 21:22 - Impact of the Macro Economic Environment 24:02 - Financing in the Biotech Industry 27:03 - Intellectual Property and Competition 30:37 - Closing Thoughts on Mentorship and Opportunities